Effects of Topical Phenylephrine HCI 2.5% used before Cataract Surgery on Systemic Blood Pressure

Basit Öğe Kaydı
dc.contributor.authorAyintap, Emre
dc.contributor.authorKeskin, Ugurcan
dc.contributor.authorCoskun, Mesut
dc.contributor.authorIlhan, Ozgur
dc.contributor.authorSemiz, Hilal
dc.contributor.authorOksuz, Huseyin
dc.date.accessioned2024-09-18T20:08:05Z
dc.date.available2024-09-18T20:08:05Z
dc.date.issued2011
dc.departmentHatay Mustafa Kemal Ãœniversitesien_US
dc.description.abstractPurpose: To evaluate the effect of topical phenylephrine HCI 2.5% (Mydfrin), used as a fast and effective mydriatic before cataract surgery, on systemic blood pressure. Material and Method: Topical phenylephrine HCI 2.5% was administered 3 times with 5-minute intervals before cataract surgery to 44 eyes of 44 patients. The systemic blood pressure was measured preoperatively and at 15 and 30 minutes. Results: The mean systolic blood pressure before the topical administration of phenylephrine HCI 2.5% was 119.7mmHg, while 15 and 30 minutes later, it was 125.3 mmHg and 121.2 mmHg, respectively. The mean diastolic blood pressure before the topical administration of phenylephrine HCI 2.5% was 75.9 mmHg; 15 and 30 minutes later, it was 76.9 mmHg and 75.3 mmHg, respectively. The increase in systolic blood pressure at 15 and 30 minutes was statistically significant (p=0.003 and p=0.042). The change in diastolic blood pressure was not statistically significant. Discussion: Phenylephrine HCI 2.5%, which is used preoperatively as a fast and effective mydriatic for cataract surgery, can increase the systolic blood pressure. This effect is most significant at 15 minutes and lasts at least 30 minutes. This agent should be used with care in hypertensive patients.en_US
dc.identifier.doi10.4274/tio.41.830070
dc.identifier.endpage166en_US
dc.identifier.issn1300-0659
dc.identifier.issn2147-2661
dc.identifier.issue3en_US
dc.identifier.startpage164en_US
dc.identifier.urihttps://doi.org/10.4274/tio.41.830070
dc.identifier.urihttps://hdl.handle.net/20.500.12483/8617
dc.identifier.volume41en_US
dc.identifier.wosWOS:000219198200007en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherTurkish Ophthalmological Socen_US
dc.relation.ispartofTurk Oftalmoloji Dergisi-Turkish Journal of Ophthalmologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCataract surgeryen_US
dc.subjectphenylephrine HCI 2.5%en_US
dc.subjectsystemic blood pressureen_US
dc.titleEffects of Topical Phenylephrine HCI 2.5% used before Cataract Surgery on Systemic Blood Pressureen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ N/A ]
Ä°sim:
Tam Metin / Full text
Boyut:
318.15 KB
Biçim:
Adobe Portable Document Format
Ä°ndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu